Breakthrough in Autoimmune Hair Loss: European Commission Approves Upadacitinib for Severe Alopecia Areata as US Patients Await FDA Review
Executive Overview Severe alopecia areata—a debilitating, unpredictable, and notoriously treatment-resistant autoimmune disorder characterized by patchy or total hair…
